Clinical Trial Update: Effect of CS1 in Subjects With Pulmonary Arterial Hypertension [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating CS1 in pulmonary arterial hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• CS1

Snippet

Sponsor: Cereno Scientific AB | Conditions: Pulmonary Arterial Hypertension | Phase 2 | Status: COMPLETED